2008 Summary
Drug Discovery & Development of Innovative Therapeutics 2008 featured 4 keynote presentations, 4 pre-conference summits, 6 therapeutics conference topics, three post-conference workshops and over 170 Exhibitors.
Almost 2,500 participants attended the conference sessions or exhibit hall this year. The keynote speakers included Elliott Sigal, M.D., Ph.D, from Bristol-Myers Squibb Company and William C. Bertrand, Jr., J.D., Executive Vice President, from MedImmune, Inc. Keynote panel discussions approached "controversial" topics such as the FDA position on biomarkers and the impact of the 2008 elections on the future of the pharmaceutical/healthcare industry.
The conference sessions covered 6 key therapeutics areas and highlighted several additional strategies to accelerate drug discovery and development: Therapeutic Advances in: Cancer, Cardio-Metabolic, Neurodegeneration, Anti-infectives, Orphan Diseases, Inflammation; Transforming Technologies; Translational Medicine; Next Generation Therapeutics; and R&D Strategies.
Over 170 drug discovery and development companies exhibited this year, including 34 new exhibitors and 47 new product launches. Key sponsors of the event include Bend Research Inc., BMG LABTECH, CambridgeSoft Corporation, ChemAxon, ForteBio, Merck, and Tata Consultancy Services.
2008 Conference Wrap Up Report
By George Miller
Do you need to write a trip report about DDT? Download the post conference summary report for the highlights and summary of the conference. All conference and exhibit hall attendees were also emailed this post show conference wrap up report directly.
 |
» Download the Post Show Wrap Up Report (523K PDF).
Updated: August 20, 2008
|
|
